BridgeBio Oncology Therapeutics BBOT Balance Sheet (2023-2026)

NASDAQ BBOT
$2.56 +0.36 (+16.36%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

BridgeBio Oncology Therapeutics Quarterly Balance Sheet

Periods 12 quarters
Latest Sep 2026

BridgeBio Oncology Therapeutics reported total assets of $346.22M and total liabilities of $52.84M for the quarter ended Sep 2026, down 28.6% year over year. This balance sheet covers 12 quarters of results from Dec 2023 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 1.84M1.81M1.79M30.85M0.96M0.66M408.74M373.69M52.66M54.06M76.48M
Short-term InvestmentsInvestments (Current) 124.78M59.54M51.77M199.62M171.65M117.39M
Cash & Current Investments 1.84M1.81M1.79M155.63M0.96M0.66M468.29M425.46M252.28M225.71M193.87M
Receivables - NetNet Receivables 0.08M0.23M0.39M0.15M0.66M0.16M
Receivables - OtherOther Receivables 9.46M9.43M0.05M-0.25M0.06M
Receivables 9.52M0.29M0.39M0.15M0.66M0.16M
Prepaid Assets 0.02M0.01M0.25M2.98M0.21M0.15M7.50M6.55M14.08M16.01M14.30M
Current Assets 2.11M2.08M2.04M158.69M1.24M0.88M476.01M432.40M266.50M242.38M208.33M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 0.49M0.83M0.96M0.94M0.88M0.82M
Long-Term Investments 185.21M187.65M190.20M192.45M194.44M196.51M136.62M118.42M121.46M
Other Non-Current Assets 0.33M0.21M0.15M0.09M5.25M5.52M12.70M11.37M12.93M13.63M
Non-Current Assets 185.42M187.80M190.29M5.61M194.44M196.51M8.78M15.99M151.14M134.33M137.90M
Assets 0.33M187.53M189.87M192.33M164.30M195.68M197.39M484.79M448.38M417.65M376.71M346.22M
Liabilities
Current Liabilities
Accounts Payables 0.01M3.07M2.52M3.65M1.37M12.09M6.73M10.26M
Notes Payables 0.07M0.48M0.09M0.11M0.69M0.53M0.72M0.99M0.23M
Payables 0.07M0.01M3.56M0.09M2.63M4.34M1.91M12.81M7.71M10.49M
Accumulated Expenses 0.02M0.02M0.08M0.13M0.12M1.78M2.52M2.09M0.67M1.43M1.94M1.65M
Other Accumulated Expenses 0.17M0.18M0.24M0.55M0.20M0.36M
Total Current Liabilities 0.40M0.02M0.08M0.13M19.58M1.87M2.63M35.71M35.04M43.26M51.63M51.03M
Non-Current Liabilities
Non-Current Deferred Revenue 5.52M
Preferred Stock Liabilities 185.21M187.65M190.20M192.45M194.44M196.51M
Operating Leases 2.38M2.24M2.11M1.96M1.81M
Other Non-Current Liabilities 5.52M5.52M5.52M5.52M5.52M5.52M
Total Non-Current Liabilities 310.87M327.80M346.02M337.42M390.19M419.60M
Total Liabilities 115.97M316.39M333.32M351.54M342.94M395.71M425.12M38.09M37.29M45.37M53.59M52.84M
Shareholder's Equity
Total Debt 0.07M0.48M0.09M0.11M0.69M0.53M0.72M0.99M0.23M
Common Equity -115.64M-128.87M-143.44M-159.21M-178.64M-200.03M-227.73M446.70M411.10M372.28M323.11M293.39M
Liabilities and Shareholders Equity 0.33M187.53M189.87M192.33M164.30M195.68M197.39M484.79M448.38M417.65M376.71M346.22M
Retained Earnings -0.09M-3.22M-3.37M-3.52M-222.52M-6.15M-7.27M-317.80M-356.57M-398.70M-455.13M-489.30M
Preferred Shares 646.72M

BridgeBio Oncology Therapeutics Balance Sheet API

Pull BridgeBio Oncology Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BBOT&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY